Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

P132 Prognosis and molecular characteristics of IBD-associated colorectal cancer: experience from a French tertiary-care center

Autor: N Hammoudi, J Lehmann-Che, J Lambert, M Amoyel, L Maggiori, D Salfati, M L Tran Minh, C Baudry, N Asesio, B Poirot, N Lourenco, H Corte, M Allez, T Aparicio, J M Gornet

Publikováno v: Journal of Crohn's and Colitis. 17:i296-i297

Background Little is known about the prognosis of colorectal cancer associated with inflammatory bowel disease (CRC-IBD) in a real-world cohort in France. Methods We conducted a retrospective observational study including all patients presenting CRC-

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::2d79dedd2aae5bc0826cec361043d63f
https://doi.org/10.1093/ecco-jcc/jjac190.0262

Loss of SMARCB1 expression in colon carcinoma

Autor: Julien Taieb, Jean-François Emile, S. Melloul, P. Laurent Puig, D. Dansette, J. Masliah-Planchon, K. Le Malicot, Julien Edeline, O. Delattre, J.-F. Mosnier, J.-M. Gornet, Côme Lepage, Patrick Texereau

Publikováno v: Cancer Biomarkers
Cancer Biomarkers, IOS Press, 2020, 27 (3), pp.399-406. ⟨10.3233/CBM-190287⟩
Cancer Biomarkers, 2020, 27 (3), pp.399-406. ⟨10.3233/CBM-190287⟩

International audience; SMARCB1 is a tumor suppressor gene, which is part of SWI/SNF complex involved in transcriptional regulation. Recently, loss of SMARCB1 expression has been reported in gastrointestinal carcinomas. Our purpose was to evaluate th

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::bbbc50db7ccc4cd0f2186ac6fbec8cce
https://doi.org/10.3233/cbm-190287

P142 Inflammatory bowel diseases associated with primary immunodeficiency: a multicenter study

Autor: G Malamut, M Simon, M Nachury, M Uzzan, M Serrero, M Fumery, C Trang-Poisson, C Zallot, V Abitbol, F Charbit-Henrion, J M Gornet, C Picard, N Cerf-Bensussan, S Chaussade, H Sokol

Publikováno v: Journal of Crohn's and Colitis. 16:i223-i224

Background Inflammatory bowel diseases (IBD) associated with primary immunodeficiency (PID) remain poorly known. We aimed to isolate characteristics of IBD associated with PID. Methods Using a GETAID register, we reviewed medical files of recorded pa

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::511915a118676c49454232ab1166564f
https://doi.org/10.1093/ecco-jcc/jjab232.270

Colorectal cancer (CRC) monitoring by 6-monthly 18FDG-PET/CT: an open-label multicentre randomised trial

Autor: E. Itti, P. Le Corvoisier, Christophe Tournigand, G. Goujon, Francois Hemery, H. Maoulida, R. Flicoteaux, Sylvie Bastuji-Garin, I. Durand Zaleski, Thierry André, Pierre-André Natella, Nicola de’Angelis, B. Rhein, M. Mons, S. Baron, Michel Ducreux, Thomas Aparicio, P. Rufat, J-B. Bachet, Richard Layese, Iradj Sobhani, Isabelle Baumgaertner, Julien Taieb, I. Cherrak, A. Retbi, Alain Luciani, J.-M. Gornet

Publikováno v: Annals of Oncology

Background [18F]2-fluoro-2-deoxy- d -glucose positron emission tomography/computed tomography (18FDG-PET/CT) has high sensitivity for detecting recurrences of colorectal cancer (CRC). Our objective was to determine whether adding routine 6-monthly 18

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0d0c644e2308a324301d0867097fce4d
https://doi.org/10.1093/annonc/mdy031